Matthew Luchini

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Matthew Luchini works at BMO and is covering the the Healthcare sector with 306 price targets and ratings documented since 2016 spanning on 23 stocks.

Matthew Luchini's average stock forecast success ratio is 46.01% with an average time for price targets to be met of 160.41 days.

Most recent stock forecast was given on GILD, Gilead Sciences, Inc at 16-May-2023.

Wall Street Analyst Matthew Luchini

Analyst best performing recommendations are on BLUE (BLUEBIRD BIO, INC).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO, INC) at 2/24/2021. The price target of $20.08 was fulfilled within 2 days with a profit of $3.3 (19.67%) receiving and performance score of 98.33.

Average potential price target upside

Currently, out of the existing stock ratings of Matthew Luchini - 49 which are a Hold (36.84%), 84 which are a Buy (63.16%)

AGTC ALXN APLS ARVN BLUE CCCC GILD ICPT IFRX KOD MDGL NG NGM REGN TCRR ONCE DBTX JSPR ETTX REPL AGLE BOLD MITO

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

0.4

$0.01 (2.56%)

7 months 16 days ago

2/2 (100%)

$0.51 (11.28%)

2

Buy

7 months 16 days ago

0/8 (0%)

$12.64 (79.14%)

Buy

12

7 months 17 days ago

0/4 (0%)

$10.17 (97.61%)

Buy

8 months 11 days ago

0/1 (0%)

$8.19 (140.96%)

Buy

11

8 months 12 days ago

0/2 (0%)

$8.27 (173.02%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership